Zenapax and Coumadin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zenapax (daclizumab) and Coumadin (warfarin sodium). Common drug interactions include atrioventricular block first degree among females and kidney transplant rejection among males.

The phase IV clinical study analyzes what interactions people have when they take Zenapax and Coumadin. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Zenapax?

Zenapax has active ingredients of daclizumab. eHealthMe is studying from 1,314 Zenapax users. Check the latest studies of Zenapax.

What is Coumadin?

Coumadin has active ingredients of warfarin sodium. It is often used in blood clots. eHealthMe is studying from 133,228 Coumadin users. Check the latest studies of Coumadin.

On Jul, 31, 2026

22 people who take Zenapax and Coumadin together, and have interactions are studied.

What are the common drug interactions of Zenapax and Coumadin, by gender? *:

female:

Atrioventricular block first degree (heart block first degree)
Back pain
Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
Blood creatinine increased
Blood pressure decreased
Blood urea increased
Breath sounds
Bronchial hyperreactivity
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

male:

Kidney transplant rejection
Drug ineffective
Blood chloride increased
Cytomegalovirus infection
Hyperglycaemia (high blood sugar)
Oedema peripheral (superficial swelling)
Peripheral ischaemia (impaired circulation to an extremity)
Pulmonary congestion (congestion in the lungs)
Pyelonephritis (inflammation of kidney caused by bacteria)
Renal abscess (pus in kidney)

What are the common drug interactions of Zenapax and Coumadin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Blood alkaline phosphatase increased
Blood creatinine increased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Pancreatitis acute (sudden inflammation of pancreas)

40-49:

Dyspnoea (difficult or laboured respiration)
Blood creatinine increased
Cardiac failure congestive
Cytomegalovirus infection
Hyperglycaemia (high blood sugar)
International normalised ratio decreased
Pulmonary congestion (congestion in the lungs)
Renal abscess (pus in kidney)
Anaemia (lack of blood)
Bk virus infection

50-59:

n/a

60+:

Blood glucose increased
Kidney transplant rejection
Blood chloride decreased
Blood phosphorus increased
Blood sodium increased
Dehydration (dryness resulting from the removal of water)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Haematocrit decreased
Haemoglobin decreased
Hypovolaemia (a decreased volume of circulating blood in the body)

* Approximation only. Some reports may have incomplete information.

Do you take Zenapax and Coumadin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously